Mark D. Deboer, Md, Msc., Mcr

This study is testing whether a new automated insulin delivery system called AIDANET is safe and practical for children aged 6-13 with type 1 diabetes. The system uses a smartphone, a special insulin pump, and a continuous glucose monitor to try to keep blood sugar levels in a he…